High expression of HOTTIP in pancreatic cancer induced gemcitabine resistance while inhibition of HOTTIP potentiated anticancer activity of gemcitabine in vitro and in vivo [83]. The gene discussed is HOTTIP; the disease is familial pancreatic carcinoma.